Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ITC Delays Patent Dispute Decision

 Posts have not been quite as helpful lately but thanks for providing your 2 cents worth.

I have been a shareholder for over a year and have been frustrated by inertia on getting out financial reports, lack of the company being "marketed to the world".

The longer I am here the more I believe that I am aware of whats going on.

The heart and soul of any company is the CEO. David Pohl took the reigns and has patiently guided, under a relative firestorm at times, PTSC. He has stated his optimism for the future at every opportunity but he has followed a focused narrrow course of making money on the IP we own. This slow approach doesn't lend itself to maximum Wall Street exposure. He has kept everything: misssion and execution to the accomplishment of one action, making the MMP portfolio a powerful tool that will, when legally proven, a force in the world of technology. He has promissed a change to another exchange in the future, a new CEO with a broader horizon and millions of dollars to play with, acquisition of companies (Holocom).

I believe we are at the cusp of the development of a great company that will slowly begin to make its mark on the world of technology.

Happy Memorial Day, David Pohl and thank you for all you do. 

Share
New Message
Please login to post a reply